CCP
ARKG icon

Clarity Capital Partners’s ARK Genomic Revolution ETF ARKG Stock Holding History

Clarity Capital Partners’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,041
Closed -$289K – 125
2024
Q1 		$289K Buy
10,041
+1,115
+12% +$33.5K 0.19% 95
2023
Q4 		$293K Buy
+8,926
New +$243K 0.21% 94

Other funds holding ARKG

MMEA
Main Management ETF Advisors San Francisco, California $3.3B AUM 33.88% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Clarity Capital Partners's ARKG Position: Q2 2024 in Review

Clarity Capital Partners sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2024, closing a stake of 10,041 shares — an estimated $289K sold.

Clarity Capital Partners first reported a position in ARKG in Q4 2023 and held it in 2 quarters. The position peaked at $293K in Q4 2023. 263 funds tracked by Wall St. Rank hold ARKG as of Q2 2024.

  • Clarity Capital Partners reported no remaining ARK Genomic Revolution ETF position as of Q2 2024 after selling out during the quarter.
  • Clarity Capital Partners sold 10,041 ARK Genomic Revolution ETF shares in Q2 2024, an estimated $289K.
  • Clarity Capital Partners first reported a position in ARK Genomic Revolution ETF in Q4 2023 and held it in 2 quarters.
  • Clarity Capital Partners's ARK Genomic Revolution ETF position peaked at $293K in Q4 2023.
  • 263 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2024.

Based on Clarity Capital Partners's 13F filing for Q2 2024, filed 30 Jul 2024.